Montreal, Canada, September 8, 2025 – Medisca, a global leader in personalized pharmaceutical medicine, entered into a long term, strategic business partnership and agreement with Stevanato Group, a world-renowned provider of pharmaceutical glass packaging and drug containment solutions, effective as of December 2024. Medisca will distribute, inter alia, Stevanato Group EZ-fill® ready-to-use (RTU) glass vials, expanding access to high-quality, efficient, and innovative solutions for the sterile compounding industry. 

Raising the bar for sterile vial solutions 

As the demand for high-quality and reliable pharmaceutical packaging continues to grow, this partnership delivers a solution that simplifies workflow and strengthens patient safety. Stevanato Group Ez-fill® RTU vials are engineered to improve the operational efficiency and reduce the contamination risk of aseptic filling processes, making them an ideal choice for compounding pharmacies and facilities, including 503A and 503B establishments. 

“We are very pleased with, and grateful for, our business partnership with Stevanato Group, a highly innovative, well-managed and global market leader in pharmaceutical containment.  With such a quality partner, we are reinforcing our commitment to provide the compounding industry with the most advanced and reliable solutions available today,” said Sanjay Goorachurn, CEO of Medisca. “This partnership addresses the industry's increasing demand for greater precision, quality, and productivity. Medisca remains focused on establishing strong partnerships with innovators in pharmaceutical manufacturing, as part of our commitment to deliver solid, safe and quality solutions in personalized medicine production.”

A powerful partnership for growth and innovation 

Stevanato Group and Medisca are leveraging their respective capabilities and expertise to bring advanced vial solutions to the pharmaceutical compounding industry, with a focus on supporting integration, innovation, and collaboration. Medisca will incorporate Stevanato EZ-fill® RTU vials into its sterile product portfolio, further expanding access to premium packaging solutions. 

“We are excited to collaborate with Medisca to distribute our EZ-fill® vials. This partnership highlights our dedication to advancing pharmaceutical packaging solutions that enhance operational efficiency and patient safety”, said Ugo Gay, President of DCS Business Unit and Shared Services at Stevanato Group. “By combining Stevanato Group's innovative technology with Medisca's extensive reach, we are poised to significantly impact the sterile compounding industry, ensuring that healthcare professionals worldwide have access to the highest quality containment solutions.” 

This collaboration strengthens access to high-quality sterile vial solutions, ensuring compounding pharmacies and facilities have reliable options to meet industry demands and support patient care. 

Availability and purchasing options pre-2026 launch 

The complete sterile containment system, including vials, stoppers, and seals, will be available for online purchase through Medisca in early 2026.Customers interested in Stevanato EZ-fill® RTU vials can request samples in select nest and tub sizes to trial the product, as Medisca is now accepting bulk material orders. To request samples, order early, and get details on pricing and lead times, customers should contact their Medisca sales representative.

About Stevanato Group 

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value-added solutions to clients. To learn more, visit: www.stevanatogroup.com. 

About Medisca 

Founded in 1989, Medisca is a leader in personalized medicine and pharmaceutical supply chain solutions, with a vast portfolio of over 2,000 products completed by a library of 10,000+ proprietary and customized medication formulas, expertise and services in pharmaceutical compounding, continuing healthcare education, and analytical testing. Providing finely-tuned solutions to diverse wellness sectors in numerous markets globally, Medisca is bridging the gaps in healthcare and empowering personalized wellness for all. For more information, visit www.medisca.com and follow us on LinkedIn, Facebook, and YouTube. 

Contact

Medisca Communications
communications@medisca.com
1-800-665-6334